Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea.

Hydroxyurea Pure erythroid leukemia Sickle cell anemia Toxicity

Journal

Case reports in oncology
ISSN: 1662-6575
Titre abrégé: Case Rep Oncol
Pays: Switzerland
ID NLM: 101517601

Informations de publication

Date de publication:
Historique:
received: 29 04 2020
accepted: 30 04 2020
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: epublish

Résumé

We present a very rare case of pure erythroid leukemia arising in a young patient with sickle cell disease being treated with hydroxyurea for almost 5 years. Diagnosing and managing this rare condition has been a challenge and the majority of patients with pure erythroid leukemia have a very poor prognosis with survival in months despite treatment. This form of leukemia could be therapy related and in our case, hydroxyurea may have been responsible for the development of this aggressive condition.

Identifiants

pubmed: 32884531
doi: 10.1159/000508361
pii: cro-0013-0857
pmc: PMC7443646
doi:

Types de publication

Case Reports

Langues

eng

Pagination

857-862

Informations de copyright

Copyright © 2020 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Am J Surg Pathol. 2012 Oct;36(10):1538-47
pubmed: 22982896
Am J Hematol. 2015 Jul;90(7):E131-2
pubmed: 25801602
Blood. 2017 May 4;129(18):2584-2587
pubmed: 28246192
Clin Med Insights Oncol. 2012;6:149-52
pubmed: 22550403
Ann Intern Med. 2011 Nov 15;155(10):722-4
pubmed: 22084346
Am J Hematol. 2013 Mar;88(3):240-1
pubmed: 22565525
Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):417-21
pubmed: 16810617
Ann Intern Med. 2000 Dec 5;133(11):925-6
pubmed: 11103075
Leukemia. 1999 Feb;13(2):250-7
pubmed: 10025899
Blood. 1998 Jan 15;91(2):616-22
pubmed: 9427717
Blood. 2010 Mar 25;115(12):2354-63
pubmed: 19903897
Histopathology. 2013 May;62(6):931-40
pubmed: 23611361
Cancer Genet Cytogenet. 2005 Dec;163(2):113-22
pubmed: 16337853
Am J Hematol. 2010 Jun;85(6):403-8
pubmed: 20513116
Saudi Med J. 2002 Nov;23(11):1411-3
pubmed: 12506308
Rare Tumors. 2018 May 14;10:2036361318773847
pubmed: 29785257
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Mod Pathol. 2018 May;31(5):705-717
pubmed: 29327715

Auteurs

Dhiraj Kumar Yadav (DK)

Department of Hematology and Oncology, Henry Ford Health System, Detroit, Michigan, USA.

Thushara Paul (T)

Department of Hematology and Oncology, Henry Ford Health System, Detroit, Michigan, USA.

Mohamed Alhamar (M)

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan, USA.

Kedar Inamdar (K)

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan, USA.

Yue Guo (Y)

Department of Hematology and Oncology, Henry Ford Health System, Detroit, Michigan, USA.

Classifications MeSH